Recent advancements in cancer research have unveiled a surprising potential therapeutic agent against one of the deadliest forms of cancer: pancreatic cancer. Central to this innovation is stevia, a plant usually celebrated for its role as a calorie-free sweetener. Now, through bacterial
In a groundbreaking move, Uniquity Bio has appointed industry veteran Will Kane as its new President and CEO amid its ambitious drive towards late-stage drug development. With over 30 years in the biopharmaceutical industry, Kane brings a wealth of experience from his previous executive roles at
In the realm of pharmaceutical research, decentralized clinical trials (DCTs) are emerging as a transformative force, promising to redefine how clinical studies are conducted. These trials address the traditional challenges that have long plagued clinical research, including limited participant
Picture the intricacies hidden within the cell—each nucleus containing a vast genome map, intricately folded into a complex three-dimensional (3D) shape. How does this hidden architecture influence the very essence of life, determining which genes are silent or expressed? The Importance of 3D DNA
The field of cancer treatment is witnessing seismic shifts as MiNK Therapeutics, a clinical-stage biotechnology firm and subsidiary of Agenus Inc., introduces groundbreaking cell-based therapies focused on treating challenging cancers. With its pioneering work on invariant natural killer T (iNKT)
Navigating the intricate world of clinical trials presents significant challenges for healthcare professionals, with a staggering 61% of U.S.-based doctors finding it difficult to identify and access suitable trials. This issue, rooted in inadequate support tools and a fragmented referral process,
